	现金及等价物		日
AbbVie	USD 6.57B	2.82B	2026-06
Amgen	USD 13.99B	1.95B	2026-06
Anika Therapeutics	USD 38.41M	2.61M	2026-06
Arrowhead Research	USD 19.68M	127.85M	2026-06
AstraZeneca	USD 4.89B	2.67B	2026-06
BioCryst Pharmaceuticals	USD 154.97M	16.62M	2026-06
Biogen	USD 1.28B	2.1B	2026-06
Bristol-Myers Squibb	USD 8.72B	852M	2026-06
Enanta Pharmaceuticals	USD 37.44M	5.14M	2025-12
Gilead Sciences	USD 7.63B	64M	2026-03
GlaxoSmithKline	GBP 3.44B	292M	2026-03
Halozyme Therapeutics	USD 163.14M	146.61M	2026-06
Heron Therapeutics	USD 20.72M	5.4M	2026-06
Immunic	USD 186.63M	171.15M	2026-03
Incyte	USD 3.98B	33.45M	2026-06
Insmed	USD 544.76M	37.42M	2026-06
Ionis Pharmaceuticals	USD 350.06M	1.57B	2026-06
J&J	USD 20.42B	1.27B	2026-06
Karyopharm Therapeutics	USD 90.85M	30.31M	2026-03
Ligand Pharmaceuticals	USD 1.01B	891.62M	2026-06
Merck	USD 6.85B	1.52B	2026-06
Neurocrine Biosciences	USD 332.4M	65.9M	2026-06
Novartis	USD 7.62B	739M	2026-06
Novavax	USD 191.46M	36.9M	2026-06
Pfizer	USD 976M	727M	2026-06
PTC Therapeutics	USD 1.05B	215.9M	2026-06
Roche Holding	CHF 7.55B	579M	2025-06
Sarepta Therapeutics	USD 571.15M	106.7M	2026-06
Vertex Pharmaceuticals	USD 7.85B	605.7M	2026-06